Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer.

Gynecologic oncology - 1 Apr 2010

Steffensen K D, Waldstrøm M, Brandslund Ivan, Jakobsen A

Abstract excerpt

OBJECTIVE: The vascular endothelial growth factor (VEGF) is an important regulator of angiogenesis and vascular permeability of tumors. In the present study we evaluated the relation of five single nucleotide polymorphisms (SNPs) in the VEGF gene with progression-free survival. Furthermore, we evaluated the functional significance of the SNPs as determined by the influence on serum VEGF levels in ovarian cancer....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Carboplatin

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Neoadjuvant Therapy

Share to Neoplasm Staging

Share to Ovarian Neoplasms

Share to Paclitaxel

Share to Vascular Endothelial Growth Factor A

Source

Identifiers

PMID: 20056267
DOI: 10.1016/j.ygyno.2009.11.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer.PMID 20056267Read ↗

Vascular Endothelial Growth Factor (VEGF) Polymorphisms and Serum VEGF Levels in Women With Epithelial Ovarian Cancer, Benign Tumors, and Healthy Ovaries.Semantic proximity Read ↗

Vascular Endothelial Growth Factor Gene Polymorphisms Are Associated with Prognosis in Ovarian CancerSemantic proximity Read ↗

VEGF gene polymorphisms and outcome of epithelial ovarian cancer patients.Semantic proximity Read ↗

Prognostic importance of vascular endothelial growth factor-A expression and vascular endothelial growth factor polymorphisms in epithelial ovarian cancer.Semantic proximity Read ↗

Association of vascular endothelial growth factor gene polymorphisms with susceptibility to epithelial ovarian cancer.Semantic proximity Read ↗

Vascular endothelial growth factor gene polymorphisms in ovarian cancer.Semantic proximity Read ↗

Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab.Semantic proximity Read ↗

Association of vascular endothelial growth factor single nucleotide polymorphisms on the prognosis of breast cancer patients.Semantic proximity Read ↗

Association of genetic polymorphisms in the VEGF gene with breast cancer survival.Semantic proximity Read ↗

Single-nucleotide polymorphisms in the vascular endothelial growth factor pathway and outcomes of patients treated with first-line cytotoxic chemotherapy combined with bevacizumab for advanced colorectal cancer.Semantic proximity Read ↗

VEGF gene polymorphisms and susceptibility to colorectal cancer.Semantic proximity Read ↗

VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.